全文获取类型
收费全文 | 28393篇 |
免费 | 6779篇 |
国内免费 | 133篇 |
专业分类
耳鼻咽喉 | 702篇 |
儿科学 | 901篇 |
妇产科学 | 905篇 |
基础医学 | 1509篇 |
口腔科学 | 2813篇 |
临床医学 | 4969篇 |
内科学 | 6423篇 |
皮肤病学 | 542篇 |
神经病学 | 2535篇 |
特种医学 | 1322篇 |
外国民族医学 | 1篇 |
外科学 | 4707篇 |
综合类 | 232篇 |
现状与发展 | 12篇 |
一般理论 | 3篇 |
预防医学 | 3409篇 |
眼科学 | 451篇 |
药学 | 872篇 |
中国医学 | 15篇 |
肿瘤学 | 2982篇 |
出版年
2024年 | 166篇 |
2023年 | 1119篇 |
2022年 | 402篇 |
2021年 | 729篇 |
2020年 | 1265篇 |
2019年 | 582篇 |
2018年 | 1435篇 |
2017年 | 1378篇 |
2016年 | 1576篇 |
2015年 | 1658篇 |
2014年 | 2101篇 |
2013年 | 2572篇 |
2012年 | 1054篇 |
2011年 | 1059篇 |
2010年 | 1510篇 |
2009年 | 2072篇 |
2008年 | 1009篇 |
2007年 | 801篇 |
2006年 | 950篇 |
2005年 | 760篇 |
2004年 | 599篇 |
2003年 | 556篇 |
2002年 | 503篇 |
2001年 | 636篇 |
2000年 | 531篇 |
1999年 | 615篇 |
1998年 | 625篇 |
1997年 | 582篇 |
1996年 | 615篇 |
1995年 | 460篇 |
1994年 | 379篇 |
1993年 | 339篇 |
1992年 | 386篇 |
1991年 | 356篇 |
1990年 | 356篇 |
1989年 | 328篇 |
1988年 | 285篇 |
1987年 | 288篇 |
1986年 | 237篇 |
1985年 | 229篇 |
1984年 | 193篇 |
1983年 | 202篇 |
1982年 | 140篇 |
1981年 | 127篇 |
1979年 | 137篇 |
1978年 | 111篇 |
1977年 | 115篇 |
1976年 | 124篇 |
1975年 | 105篇 |
1974年 | 101篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
David W. Farley DDS John D. Jones DDS Robert J. Cronin DDS MS 《Journal of prosthodontics》1998,7(2):84-90
Phonetics, esthetics, function, and comfort form the foundation of a successful dental prosthesis. A review of the mechanics of speech as well as common speech problems encountered with a removable maxillary prosthesis are presented. The use of a palatogram to aid the clinician in the assessment and resolution of speech problems associated with a maxillary denture is demonstrated. 相似文献
72.
1. Opioid receptors have been localised on sensory fibres in the vagus nerve and opioids have previously been shown to inhibit non-adrenergic, non-cholinergic (NANC) neurotransmission in guinea-pig bronchi in vitro and in vivo. We have now investigated whether an inhibitory effect could be demonstrated on cholinergic neurotransmission. 2. Electrical field stimulation (EFS) (8 Hz, 0.5 ms, 40 V for 20 s) produced only a rapid, cholinergic response in the upper trachea but in the lower trachea and main bronchi a cholinergic response which was atropine-sensitive and a longer lasting NANC contraction that was atropine-insensitive was demonstrated. This slow contraction could be blocked by tetrodotoxin and capsaicin pretreatment. 3. [D-Ala2, NMePhe4, Gly-ol5]enkephalin (DAMGO), a selective mu-opioid receptor agonist, inhibited the cholinergic response to EFS at 8 Hz in a dose-dependent manner in main bronchi (IC50 = 113 nM with a maximal inhibition of 35.7 +/- 5.6% 10 microM, n = 5). In the lower trachea, DAMGO inhibited the cholinergic response to a similar extent (inhibition of 35.8 +/- 3.5% at 10 microM, n = 5). However, DAMGO had no effect on the contractile response to exogenously applied acetylcholine in the main bronchi. By contrast, opioids had no inhibitory effect on cholinergic neurotransmission in the upper trachea. DAMGO (1 microM) inhibited the cholinergic response to EFS in a frequency-dependent manner in the main bronchi with greater inhibition at lower frequencies of stimulation.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
73.
Syntheses of several tripeptide analogues of leupeptin containing C-terminal argininal, lysinal, or ornithinal units are presented. The synthetic analogues were tested as inhibitors of trypsin, plasmin, and kallikrein. (Benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a) was significantly less effective as an inhibitor of trypsin and plasmin activity than leupeptin. (Benzyloxycarbonyl)-L-leucyl-L-leucyl-L-lysinal (2e) and (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-ornithinal (2i) display different inhibition characteristics than (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a). While (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a) showed moderate inhibition of all three enzymes tested, (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-lysinal (2e) was less effective as an inhibitor of trypsin and plasmin activity. Of the three enzymes tested, (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-ornithinal (2i) showed significant inhibition of kallikrein activity only. Modifications made in the composition and sequence of the P2 and P3 amino acids also resulted in variations in the inhibitory activity of the analogues. In general, plasmin showed a strong preference for inhibitors which contain an L-phenylalanyl-L-leucyl or an L-leucyl-L-valyl unit in the P2 and P3 positions. 相似文献
74.
75.
76.
A case of obstructive sleep apnoea is reported that was caused by a dermoid cyst of the floor of the mouth and cured by surgery. 相似文献
77.
School-Based Cardiovascular Health Promotion: The Child and Adolescent Trial for Cardiovascular Health (CATCH) 总被引:7,自引:0,他引:7
Cheryl L. Perry PhD Elaine J. Stone PhD MPH FASHA Guy S. Parcel PhD FASHA R. Curtis Ellison MD Philip R. Nader MD FASHA Larry S. Webber PhD Russell V. Luepker MD MS 《The Journal of school health》1990,60(8):406-413
The Child and Adolescent Trial for Cardiovascular Health (CATCH) is a multisite intervention research study that builds on significant progress made in school health education research in the 1980s. The study has three phases: Phase I deals with study design, intervention, and measurement development, Phase II involves the main trial in 96 schools in four states, and Phase III focuses on analysis. The intervention program targets third-fifth grade students and focuses on multiple cardiovascular health behaviors, including eating habits, physical activity, and cigarette smoking. Classroom curricula, school environmental change, and family involvement programs are developed for each grade level and behavioral focus. This paper describes Phase II of CATCH with a rationale for cardiovascular health promotion with youth. The process of change that appears to be necessary for school-based health promotion and that will be tested in CATCH are presented as a framework to guide these efforts. 相似文献
78.
79.
80.